RMBIO
Private Company
Funding information not available
Overview
RMBIO is a private, revenue-generating company that has established itself as a key supplier of critical cell culture components, including its flagship FBS replacement product, Fetalgro. Leveraging a state-of-the-art manufacturing facility and proprietary purification methods, the company caters to diverse sectors including pharmaceuticals, academia, and animal health. Its business model is primarily service and product-based, providing essential biologics and reagents rather than developing therapeutic drugs. With a focus on quality and traceability, RMBIO aims to be a reliable partner in the life sciences supply chain.
Technology Platform
Proprietary extraction and purification methods for serum fractionation and production of cell culture supplements, including FBS-alternative Fetalgro.
Opportunities
Risk Factors
Competitive Landscape
RMBIO competes in the crowded life science reagents market against giants like Thermo Fisher Scientific, Merck Millipore, and Sartorius, as well as other specialized serum producers such as Bovogen and Moregate Biotech. Its differentiation is based on proprietary alternatives (Fetalgro), ISIA traceability certification, and a focus on high-touch service and customization for specific client needs.